|
[1] Cortright J, Mayer H. Signs of life: the growth of biotechnology centers in the U. S. The Brookings Institution. June 2002. http://www.brookings.edu/reports/2002/06_biotechnology_cortright.aspx.
[2] 李志能, 苑波, 陈波. 形成和确保代际优势——美国生物技术产业集群的发展和组织状况. 中国生物工程杂志. 2006, 26(1):97-101. Li Z N, Yuan B, Chen B.China Biotechnology, 2006,26(1):97-101.
[3] Battle technology partnershi Ppractice. Battelle/BIO State Bioscience Initiatives 2010. Battelle Memorial Institute.2010.http://www.bio.org/local/battelle2010/.
[4] 王钢, 张朝国, 刘军伟. 欧洲生物科技产业发展的经验与启示. 浙江经济. 2010,9:48-50. Wang G, Zhang C G, Liu J W.Zhejiang Economy. 2010,9:48-50.
[5] 科学技术部社会发展司. 生物医药发展战略报告-园区篇.北京:科学出版社,2009. Social Development Department of the Ministry of Science and Technology. Report of Biopharmaceutical Development Strategy-Industrial Parks. Beijing: Science Press, 2009.
[6] Okamoto Y. Paradox of Japanese Biotechnology: Can the Regional Cluster Development Approach be a Solution? Dec.1st, 2008.http://www.imit.se/pdf/reports/2009_211.pdf.
[7] 张鹏, 赵丹玲, 芮国忠. 我国生物医药产业园区运营模式的思考. 中国医药技术经济与管理. 2009,3(12):36-39. Zhang P, Zhao D L, Rui G Z. Chinese Journal of Pharmaceutical Technology Economics and Management. 2009, 3(12):36-39.
|
